Prosus Valuation

Is PRX undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of PRX when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: PRX (€37.97) is trading above our estimate of fair value (€26.51)

Significantly Below Fair Value: PRX is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for PRX?

Key metric: As PRX is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for PRX. This is calculated by dividing PRX's market cap by their current earnings.
What is PRX's PE Ratio?
PE Ratio13.7x
EarningsUS$6.88b
Market CapUS$94.14b

Price to Earnings Ratio vs Peers

How does PRX's PE Ratio compare to its peers?

The above table shows the PE ratio for PRX vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average32.3x
JD JD.com
10.4x8.2%US$50.3b
WES Wesfarmers
32.1x8.2%AU$80.5b
BABA Alibaba Group Holding
16x14.9%US$189.0b
MELI MercadoLibre
70.7x28.0%US$101.6b
PRX Prosus
13.7x4.8%€90.4b

Price-To-Earnings vs Peers: PRX is good value based on its Price-To-Earnings Ratio (13.7x) compared to the peer average (32.2x).


Price to Earnings Ratio vs Industry

How does PRX's PE Ratio compare vs other companies in the Global Multiline Retail Industry?

6 CompaniesPrice / EarningsEstimated GrowthMarket Cap
PRX 13.7xIndustry Avg. 19.8xNo. of Companies20PE01632486480+
6 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: PRX is good value based on its Price-To-Earnings Ratio (13.7x) compared to the Global Multiline Retail industry average (19.8x).


Price to Earnings Ratio vs Fair Ratio

What is PRX's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

PRX PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio13.7x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate PRX's Price-To-Earnings Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst PRX forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€37.97
€47.41
+24.8%
15.2%€65.03€37.00n/a17
Nov ’25€39.30
€46.46
+18.2%
16.3%€65.03€36.00n/a17
Oct ’25€40.00
€44.34
+10.9%
11.4%€54.86€36.00n/a17
Sep ’25€33.81
€44.34
+31.2%
11.4%€54.86€36.00n/a17
Aug ’25€32.26
€43.76
+35.7%
12.4%€54.86€34.00n/a18
Jul ’25€33.54
€43.12
+28.6%
13.7%€54.86€33.00n/a18
Jun ’25€33.54
€42.69
+27.3%
13.6%€52.00€33.00n/a18
May ’25€31.69
€42.83
+35.2%
20.9%€74.00€33.00n/a17
Apr ’25€29.08
€42.23
+45.2%
21.4%€74.00€32.00n/a18
Mar ’25€27.18
€42.62
+56.8%
21.7%€74.00€32.00n/a18
Feb ’25n/a
€42.45
0%
21.6%€74.00€32.00n/a18
Jan ’25€26.84
€43.22
+61.1%
21.5%€74.00€32.00n/a17
Dec ’24€30.03
€43.19
+43.8%
21.5%€74.00€32.00n/a17
Nov ’24€26.50
€41.25
+55.6%
13.1%€49.40€32.00€39.3016
Oct ’24€28.12
€41.00
+45.8%
13.2%€49.40€32.00€40.0016
Sep ’24€28.72
€41.76
+45.4%
12.9%€50.47€33.03€33.8117
Aug ’24€32.95
€41.42
+25.7%
12.6%€50.47€33.03€32.2617
Jul ’24€29.15
€40.77
+39.9%
13.3%€50.47€32.12€33.5418
Jun ’24€28.87
€40.49
+40.2%
13.0%€48.63€30.74€33.5419
May ’24€31.29
€40.51
+29.5%
13.3%€49.55€30.74€31.6919
Apr ’24€33.01
€40.55
+22.8%
14.3%€49.55€29.82€29.0818
Mar ’24€30.95
€40.52
+30.9%
13.6%€49.55€29.82€27.1820
Feb ’24€34.10
€39.73
+16.5%
13.8%€49.55€29.82n/a20
Jan ’24€30.03
€38.62
+28.6%
12.8%€48.63€29.82€26.8419
Dec ’23€28.52
€37.39
+31.1%
13.4%€47.72€29.82€30.0319
Nov ’23€22.31
€39.81
+78.4%
15.7%€50.47€28.45€26.5019

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies